Zai Lab Ltd (ZLAB)
21.02
+4.45
(+26.86%)
USD |
NASDAQ |
May 09, 16:00
20.95
-0.07
(-0.33%)
After-Hours: 06:12
Zai Lab Enterprise Value: 1.473B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 1.473B |
| May 08, 2024 | 1.033B |
| May 07, 2024 | 1.044B |
| May 06, 2024 | 1.067B |
| May 03, 2024 | 1.002B |
| May 02, 2024 | 1.035B |
| May 01, 2024 | 974.91M |
| April 30, 2024 | 964.99M |
| April 29, 2024 | 996.74M |
| April 26, 2024 | 975.90M |
| April 25, 2024 | 959.04M |
| April 24, 2024 | 925.38M |
| April 23, 2024 | 872.70M |
| April 22, 2024 | 860.01M |
| April 19, 2024 | 770.25M |
| April 18, 2024 | 784.89M |
| April 17, 2024 | 736.10M |
| April 16, 2024 | 804.40M |
| April 15, 2024 | 782.93M |
| April 12, 2024 | 793.67M |
| April 11, 2024 | 858.40M |
| April 10, 2024 | 896.35M |
| April 09, 2024 | 956.70M |
| April 08, 2024 | 905.11M |
| April 05, 2024 | 908.03M |
| Date | Value |
|---|---|
| April 04, 2024 | 901.22M |
| April 03, 2024 | 945.02M |
| April 02, 2024 | 958.64M |
| April 01, 2024 | 1.025B |
| March 31, 2024 | 956.70M |
| March 28, 2024 | 782.87M |
| March 27, 2024 | 799.74M |
| March 26, 2024 | 775.93M |
| March 25, 2024 | 805.69M |
| March 22, 2024 | 798.75M |
| March 21, 2024 | 904.90M |
| March 20, 2024 | 900.93M |
| March 19, 2024 | 1.006B |
| March 18, 2024 | 987.24M |
| March 15, 2024 | 1.026B |
| March 14, 2024 | 1.133B |
| March 13, 2024 | 1.194B |
| March 12, 2024 | 1.132B |
| March 11, 2024 | 1.179B |
| March 08, 2024 | 1.070B |
| March 07, 2024 | 1.094B |
| March 06, 2024 | 1.158B |
| March 05, 2024 | 1.070B |
| March 04, 2024 | 1.219B |
| March 01, 2024 | 1.287B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-182.09M
Minimum
Aug 12 2019
16.07B
Maximum
Jun 01 2021
3.708B
Average
1.960B
Median
Nov 20 2023
Enterprise Value Benchmarks
| Dr Reddy's Laboratories Ltd | 10.76B |
| Concord Medical Services Holdings Ltd | 993.05M |
| WuXi Biologics (Cayman) Inc | 6.896B |
| I-MAB | -162.56M |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -53.47M |
| Revenue (Quarterly) | 87.15M |
| Total Expenses (Quarterly) | 157.46M |
| EPS Diluted (Quarterly) | -0.50 |
| Gross Profit Margin (Quarterly) | 61.42% |
| Profit Margin (Quarterly) | -61.36% |
| Earnings Yield | -16.65% |
| Normalized Earnings Yield | -15.87 |